GX-03
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GX-03, covering 2021-07-06 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic Dermatitis) [Phase 2]